To be or not to be: how does the brain respond to different infectious agents?
- PMID: 40762468
- PMCID: PMC12379583
- DOI: 10.1128/msphere.00326-25
To be or not to be: how does the brain respond to different infectious agents?
Abstract
Toxoplasma gondii is an apicomplexan parasite that chronically infects approximately 30% of the global population. In healthy adults, infection is typically resolved within a few weeks, resulting in tissue cysts that persist in the central nervous system for the lifetime of the host. In immune-compromised patients, infection can manifest as toxoplasmic encephalitis and blindness. Additionally, there are several neurological and psychiatric associations with toxoplasmosis, including but not limited to epilepsy and bipolar disorder. This commentary reflects on recent work by Johnson and colleagues (H. J. Johnson, J. A. Kochanowsky, S. Chandrasekaran, C. A. Hunter, et al., mSphere 10:e00216-25, 2025, https://doi.org/10.1128/msphere.00216-25) investigating the difference in neuronal response to T. gondii compared to neurotropic West Nile and Zika viruses. They identify unique neurological and immune signatures associated with the different infections, as well as overlapping pathways enriched regardless of pathogen type. This study provides insights into host signaling pathways that can be manipulated for therapies against toxoplasmosis.
Keywords: Toxoplasma; brain; flavivirus; immunity; infection; neuron.
Conflict of interest statement
The authors declare no conflict of interest.
Comment on
-
Defining neuronal responses to the neurotropic parasite Toxoplasma gondii.mSphere. 2025 Jun 25;10(6):e0021625. doi: 10.1128/msphere.00216-25. Epub 2025 May 30. mSphere. 2025. PMID: 40444956 Free PMC article.
References
-
- Daniels BP, Kofman SB, Smith JR, Norris GT, Snyder AG, Kolb JP, Gao X, Locasale JW, Martinez J, Gale M Jr, Loo Y-M, Oberst A. 2019. The nucleotide sensor ZBP1 and kinase RIPK3 induce the enzyme IRG1 to promote an antiviral metabolic state in neurons. Immunity 50:64–76. doi: 10.1016/j.immuni.2018.11.017 - DOI - PMC - PubMed
-
- Eberhard JN, Shallberg LA, Winn A, Chandrasekaran S, Giuliano CJ, Merritt EF, Willis E, Konradt C, Christian DA, Aldridge DL, Bunkofske ME, Jacquet M, Dzierszinski F, Katifori E, Lourido S, Koshy AA, Hunter CA. 2025. Immune targeting and host-protective effects of the latent stage of Toxoplasma gondii. Nat Microbiol 10:992–1005. doi: 10.1038/s41564-025-01967-z - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical